×

Wound care vacuum bandaging in combination with acoustic shock wave applications

  • US 8,057,411 B2
  • Filed: 04/25/2007
  • Issued: 11/15/2011
  • Est. Priority Date: 04/25/2007
  • Status: Active Grant
First Claim
Patent Images

1. An acoustic shock wave and vacuum wound treatment device for application to tissue, the device comprising:

  • a porous padding for application upon a treatment surface of the tissue;

    an air tight water vapor permeable foil or sealing cover for covering the treatment surface and the porous padding which seals the treatment surface from air;

    at least one fluid supply line for supplying fluid to the treatment surface and the porous pad;

    at least one fluid removal line for removing fluid from the treatment surface and the porous padding, the removal line being to a vacuum line, wherein the introduction of fluids through the supply line in combination with the removal of fluids and entrapped air through the removal line thereby fluid saturates the porous pad and treatment surface; and

    whereinan acoustic shock wave applicator head device being acoustically coupled to either the foil or sealing cover, the foil or sealing cover and adjacent tissue or the adjacent tissue for transmission of acoustic shock waves to the treatment surface through the fluid saturated porous padding, and wherein the transmission of acoustic shock waves are emitted from the shock wave applicator as pressure pulses or acoustic shock waves in a transmission dosage directed toward the treatment surface of the tissue to impinge the tissue of a wound with pressure pulses or shock waves having a low energy density in the range of 0.00001 mJ/mm2 to 1.0 mJ/mm2;

    the pressure pulse being an acoustic pulse which includes several cycles of positive and negative pressure, wherein the pressure pulse has an amplitude of the positive part of such a cycle above 0.1 MPa and the time duration of the pressure pulse is from below a microsecond to a second, rise times of the positive part of the first pressure cycle being in the range of nano-seconds (ns) up to some milli-seconds (ms), the acoustic shock waves being very fast pressure pulses having amplitudes above 0.1 MPa and rise times of the amplitude being below 100'"'"'s of ns, the duration of the shock wave is typically below 1-3 micro-seconds (μ

    s) for the positive part of a cycle and typically above some micro-seconds for the negative part of a cycle;

    wherein the transmission dosage subjects the tissue of the wound to convergent, divergent, planar or near planar acoustic shock waves or pressure pulses in the absence of a focal point impinging the substance stimulating a cellular response in the absence of creating cavitation bubbles evidenced by not experiencing the sensation of increased cellular hemorrhaging in the tissue of the wound caused by the emitted waves or pulses in the tissue of the wound wherein the tissue of the wound is positioned within a path of the emitted shock waves or pressure pulses and away from any localized geometric focal volume or point of the emitted shock waves wherein the emitted shock waves or pressure pulses either have no geometric focal volume or point or have a focal volume or point ahead of the tissue of the wound or beyond the tissue of the wound thereby passing the emitted waves through the tissue of the wound while avoiding having any localized focal point within the tissue of the wound and wherein the emitted pressure pulses or shock waves are convergent, divergent, planar or near planar and the pressure pulse shock wave is based on electro-hydraulic, electromagnetic, piezoceramic or ballistic wave generation having an energy density value ranging as low as 0.00001 mJ/mm2 to a high end of below 1.0 mJ/mm2.

View all claims
  • 3 Assignments
Timeline View
Assignment View
    ×
    ×